Matthew Plavan

2015 - Cesca Therapeutics

In 2015, Matthew Plavan earned a total compensation of $1M as CEO thru October 28, at Cesca Therapeutics, a 2% decrease compared to previous year.

Compensation breakdown

Option Awards$304,000
Salary$142,000
Other$560,000
Total$1,006,000

Plavan received $560K in other compensation, accounting for 56% of the total pay in 2015.

Plavan also received $304K in option awards and $142K in salary.

Rankings

In 2015, Matthew Plavan's compensation ranked 7,924th out of 13,638 executives tracked by ExecPay. In other words, Plavan earned more than 41.9% of executives.

ClassificationRankingPercentile
All
7,924
out of 13,638
42nd
Division
Manufacturing
3,009
out of 5,190
42nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
396
out of 760
48th
Industry group
Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments
130
out of 234
44th
Industry
Laboratory Apparatus and Furniture
4
out of 14
71st
Source: SEC filing on January 14, 2016.

Plavan's colleagues

We found seven more compensation records of executives who worked with Matthew Plavan at Cesca Therapeutics in 2015.

2015

Robin Stracey

Cesca Therapeutics

Chief Executive Officer

2015

Dan Bessey

Cesca Therapeutics

Chief Financial Officer

2015

Ken Harris

Cesca Therapeutics

Former President

2015

Mitchel Sivilotti

Cesca Therapeutics

Former Chief Biologist

2015

Ray DeGrella

Cesca Therapeutics

VP, Quality & Regulatory Affairs thru September 10,

2015

Michael Bruch

Cesca Therapeutics

Chief Financial Officer

2015

Kim Ellner

Cesca Therapeutics

VP, Manufacturing & Global Supply Chain

News

You may also like